Horsham, PA, United States of America

Teresa Duda

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Salus University. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Teresa Duda. Retrieved from https://idiyas.com/inventor/teresa-duda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Teresa Duda: Innovator in Transgenic Animal Research

Introduction

Teresa Duda is a prominent inventor based in Horsham, PA (US). She has made significant contributions to the field of genetic research, particularly in the development of transgenic animals. Her work focuses on understanding the effects of specific protein mutations on various biological pathways.

Latest Patents

Teresa Duda holds a patent for her invention titled "ANF-RGC in-gene knock-out animal." This patent describes transgenic animals that possess a mutation or deletion in the ANF-RGC protein, specifically targeting its ARM and/or ATS-ST regions. These animals are valuable for studying the pathways associated with ANF-RGC activation, including hypertension. Additionally, they can be utilized in drug screening assays and to establish toxicity profiles.

Career Highlights

Teresa Duda is affiliated with Salus University, where she continues her research and innovation in the field of genetic engineering. Her work has garnered attention for its potential applications in medical research and drug development.

Collaborations

Teresa collaborates with Rameshwar K Sharma, contributing to advancements in their shared field of study.

Conclusion

Teresa Duda's innovative work in transgenic animal research exemplifies the impact of genetic engineering on understanding complex biological processes. Her contributions are paving the way for future advancements in medical research and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…